Form D · Other Technology
Cohere Health Inc.
Boston, MA · CIK 0001851745
Offering snapshot reported May 22, 2025 · SEC filing
- Reported sold
- $90M Offering amount: $90M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 7, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 22, 2025 | Initial | $89,999,876 | No comparison | 8 | SEC filing |
| Feb 1, 2024 | Initial | $39,999,987 | No comparison | 7 | SEC filing |
| Apr 14, 2021 | Initial | $36,099,972 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-546971
Source: Form D, filed May 22, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Barrett | Director |
| Kristen Carucci | Executive |
| Amir Debourou | Director |
| Gary L. Gottlieb | Director |
| Gary L. Gottlieb, M.D. | Director |
| Michael Greeley | Director |
| Julian Harris | Director |
| Carrie Milby | Director |
| Siva Namasivayam | Director, Executive |
| Duncan Reese | Executive |
| Robert Shepardson | Executive |
| William H. Shrank, M.D. | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
226 Causeway Street, Suite 403
Boston, MA, 02114
Boston, MA, 02114